O5 Hepatitis C elimination in HIV/HCV co-infection through HCV treatment in primary care is feasible and highly effective

O5 Hepatitis C elimination in HIV/HCV co-infection through HCV treatment in primary care is feasible and highly effective

Bibliographic Details
Main Authors:	J.S. Doyle, A.L. Bowring, J. Cutts, J. Roney, D.M. Iser, J. Sasadeusz, M. O’Reilly, C. Fairley, E. Gane, J. Hoy, G.V. Matthews, N. Medland, R. Moore, M. Prins, M. Stoové, B.K. Tee, M.E. Hellard
Format:	Article
Language:	English
Published:	Elsevier 2017-08-01
Series:	Journal of Virus Eradication
Online Access:	http://www.sciencedirect.com/science/article/pii/S2055664020308888

Similar Items

O20 Opportunities and challenges experienced when treating HCV in people who inject drugs (PWID) through a nurse-led outreach model
by: K. Allardice, et al.
Published: (2017-08-01)

HCV Seroreactivity and Detection of HCV RNA in Hepatitis Cases
by: Mahantesh B Nagamoti, et al.
Published: (2018-04-01)

Complementary role of HCV and HIV in T-cell activation and exhaustion in HIV/HCV coinfection.
by: Thijs Feuth, et al.
Published: (2013-01-01)

Human monoclonal antibody HCV1 effectively prevents and treats HCV infection in chimpanzees.
by: Trevor J Morin, et al.
Published: (2012-01-01)

HCV and Oxidative Stress: Implications for HCV Life Cycle and HCV-Associated Pathogenesis
by: Regina Medvedev, et al.
Published: (2016-01-01)

ANTI-HCV. CONFRONTO TRA SISTEMI IN AUTOMAZIONE.ANTI-HCV-ARCHITECT (ABBOTT) VERSO ANTI-HCV-VITROS (ORTHO).
by: M. Marinelli, et al.
Published: (2003-06-01)

Is HCV elimination possible in prison?
by: J. Crespo, et al.

Feasibility of anti-HCV reflex HCV Ag screening strategy in an HCV endemic community
by: Wei-Ming Chen, et al.
Published: (2021-05-01)

Treatment of HCV and HIV coinfection
by: J. Alberto Juárez Navarro
Published: (2006-01-01)

O7 Moving towards HCV elimination in HIV/HCV co- infection in Australia following universal access to interferon-free therapy
by: Marianne Martinello, et al.
Published: (2017-08-01)

HCV Specific IL-21 Producing T Cells but Not IL-17A Producing T Cells Are Associated with HCV Viral Control in HIV/HCV Coinfection.
by: Sonya A MacParland, et al.
Published: (2016-01-01)

Effect of combined siRNA of HCV E2 gene and HCV receptors against HCV
by: Ashfaq Usman Alli A, et al.
Published: (2011-06-01)

Venue-Based Networks May Underpin HCV Transmissions amongst HIV-Infected Gay and Bisexual Men.
by: Daniel Bradshaw, et al.
Published: (2016-01-01)

Virological impact of HCV elimination with DAAs in the HIV reservoir in HIV/HCV patients
by: M. Coiras, et al.
Published: (2019-12-01)

LINFOMI E VIRUS HCV
by: M. Spinosa, et al.
Published: (2005-09-01)

Immune biomarker differences and changes comparing HCV mono-infected, HIV/HCV co-infected, and HCV spontaneously cleared patients.
by: Lauren E Kushner, et al.
Published: (2013-01-01)

The burgeoning HIV/HCV syndemic in the urban Northeast: HCV, HIV, and HIV/HCV coinfection in an urban setting.
by: Jamie P Morano, et al.
Published: (2013-01-01)

Contemporary HCV pangenotypic DAA treatment protocols are exclusionary to real world HIV-HCV co-infected patients
by: A. Maughan, et al.
Published: (2019-05-01)

HCV and Lymphoproliferation
by: Anna Linda Zignego, et al.
Published: (2012-01-01)

HCV resistance
by: Halfon Philippe
Published: (2012-05-01)

CONFRONTO TRA SISTEMI DIAGNOSTICI MOLECOLARI PER LA DEFINIZIONE DELLA VIRAL LOAD DI HCV: COBAS AMPLICOR MONITOR HCV 2.0,VERSANT B-DNA HCV 3.0, E COBAS TAQMAN HCV
by: P. Ravanini, et al.
Published: (2006-09-01)

Lack of HCV Replication during the Course of HCV-Associated Arthritis
by: A. Riccio, et al.
Published: (2008-09-01)

LncRNAs in HCV Infection and HCV-Related Liver Disease
by: Juan P. Unfried, et al.
Published: (2020-03-01)

Hepatitis C (HCV) therapy for HCV mono-infected and HIV-HCV co-infected individuals living in Nepal.
by: Sudhamshu Kc, et al.
Published: (2020-12-01)

Comparative studies in detection of anti-HCV antibodies using Abbott IMx HCV, Serodia-HCV and DETECT-HCVTM
by: Nisarat Apichartpiyakul, et al.
Published: (2010-01-01)

Key Elements on the Pathway to HCV Elimination: Lessons Learned From the AASLD HCV Special Interest Group 2020
by: Jordan J. Feld, et al.
Published: (2021-06-01)

Expression of hepatitis C virus (HCV) structural proteins in trans facilitates encapsidation and transmission of HCV subgenomic RNA
by: Adair, R., et al.
Published: (2009)

Successful outcome of transplanting a kidney from a HCV-positive deceased donor into a HCV-negative recipient
by: Zaheer Amin Virani, et al.
Published: (2018-01-01)

MIGLIORAMENTI NELLA DETERMINAZIONE DEI GENOTIPI HCV MEDIANTE L’UTILIZZO DEL VERSANT HCV GENOTYPE 2.0 (INNO-LIPA HCV 2.0)
by: R. Sabatini, et al.
Published: (2007-09-01)

Prevalence of hepatitis C virus (HCV) infection and HCV genotypes of hemodialysis patients in Salvador, Northeastern Brazil
by: L.K. Silva, et al.
Published: (2006-05-01)

HCV genotyping from NGS short reads and its application in genotype detection from HCV mixed infected plasma.
by: Ping Qiu, et al.
Published: (2015-01-01)

Pharmacologic management of HCV treatment in patients with HCV monoinfection vs. HIV/HCV coinfection: Does coinfection really matter?
by: Autumn D Zuckerman, et al.
Published: (2019-01-01)

Alcohol Consumption and Hepatitis C Virus (HCV) RNA Levels in HIV/HCV Coinfected Patients
by: Daniel Fuster, et al.
Published: (2021-04-01)

HCV-RNA-PCR TEST QUANTITATIVO
by: M. Spinosa, et al.
Published: (2005-09-01)

Detection rate of specific antibodies to the HCV CORE+1 protein in “naive” cronically HCV-infected patients in depends on the stage of liver fibrosis and the HCV subtype
by: E. V. Lichnaya, et al.
Published: (2021-01-01)

RICERCA DEL GENOTIPO HCV IN UNA POPOLAZIONE DI TALASSEMICI, HCV POSITIVI, DELLA LOCRIDE.
by: R. Romeo, et al.
Published: (2005-09-01)

Correlates of HCV seropositivity among familial contacts of HCV positive patients
by: Matera Antonio, et al.
Published: (2006-09-01)

HCV-Specific T Cell Responses During and After Chronic HCV Infection
by: Hendrik Luxenburger, et al.
Published: (2018-11-01)

ANTI - HCV : DIAGNOSI DI LABORATORIO
by: A. Migliozzi, et al.
Published: (2005-09-01)

Frequencies of Circulating MAIT Cells Are Diminished in Chronic HCV, HIV and HCV/HIV Co-Infection and Do Not Recover during Therapy.
by: Michelle Spaan, et al.
Published: (2016-01-01)